MIST - Milestone Pharmaceuticals EPS beats by $0.28 beats on revenue August, 11 2021 04:56 PM Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals (NASDAQ:MIST): Q2 GAAP EPS of $0.02 beats by $0.28. Revenue of $15M beats by $12M. Shares +2.4%. Press Release For further details see: Milestone Pharmaceuticals EPS beats by $0.28, beats on revenue